Inventiva S.A. Sponsored ADR (NASDAQ:IVA – Get Free Report)’s share price gapped up before the market opened on Monday. The stock had previously closed at $3.68, but opened at $3.81. Inventiva shares last traded at $3.5950, with a volume of 236,477 shares traded.
Wall Street Analyst Weigh In
Several equities analysts have commented on the company. Wall Street Zen upgraded Inventiva from a “sell” rating to a “hold” rating in a report on Saturday, October 3rd. Guggenheim boosted their price objective on shares of Inventiva from $11.00 to $14.00 and gave the stock a “buy” rating in a research note on Tuesday, September 15th. Truist Financial upped their price objective on shares of Inventiva from $13.00 to $18.00 and gave the stock a “buy” rating in a report on Friday, October 2nd. Weiss Ratings lowered shares of Inventiva from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday. Finally, Piper Sandler reiterated an “overweight” rating on shares of Inventiva in a research note on Wednesday, September 16th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $14.67.
Get Our Latest Stock Report on Inventiva
Inventiva Stock Down 6.7%
The company has a 50-day simple moving average of $3.64 and a 200 day simple moving average of $4.76.
Inventiva (NASDAQ:IVA – Get Free Report) last announced its quarterly earnings data on Friday, August 14th. The company reported ($0.14) earnings per share (EPS) for the quarter. The firm had revenue of $0.75 million for the quarter. On average, equities analysts anticipate that Inventiva S.A. Sponsored ADR will post -0.75 earnings per share for the current year.
Institutional Trading of Inventiva
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Commonwealth Equity Services LLC raised its stake in shares of Inventiva by 7.0% in the 3rd quarter. Commonwealth Equity Services LLC now owns 89,853 shares of the company’s stock valued at $332,000 after buying an additional 5,857 shares in the last quarter. Platt Investment Counsel LLC acquired a new stake in shares of Inventiva during the 3rd quarter valued at about $45,000. China Universal Asset Management Co. Ltd. boosted its position in shares of Inventiva by 78.7% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 38,600 shares of the company’s stock valued at $142,000 after acquiring an additional 17,000 shares in the last quarter. Engineers Gate Manager LP boosted its position in shares of Inventiva by 155.5% during the 2nd quarter. Engineers Gate Manager LP now owns 71,116 shares of the company’s stock valued at $269,000 after acquiring an additional 43,280 shares in the last quarter. Finally, Seven Fleet Capital Management LP bought a new stake in Inventiva in the first quarter valued at about $1,111,000. 19.06% of the stock is currently owned by institutional investors and hedge funds.
Inventiva Company Profile
Inventiva S.A. is a clinical-stage biopharmaceutical company headquartered in Daix, France. Founded in 2011, the company focuses on developing oral treatments for metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease associated with metabolic disorders. Inventiva’s lead drug candidate is lanifibranor, an investigational pan-peroxisome proliferator-activated receptor (pan-PPAR) agonist being evaluated in the Phase 3 NATiV3 clinical trial. The company expects topline trial results in Q4 2026 and, if results are positive, plans to pursue U.S. regulatory approval, with a potential commercial launch in 2028.
Featured Articles
- Five stocks we like better than Inventiva
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
- Embraer’s Record Backlog Looks Promising, But Can It Keep Its Margins Climbing?
- Could Big Buybacks Be the Next Catalyst for These 3 AI Stocks?
- 3 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?
Receive News & Ratings for Inventiva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inventiva and related companies with MarketBeat.com's FREE daily email newsletter.
